ARCHIVES

Transplant Is Viable Option For HIV+ Patients, Study Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 2 | February 25, 2005

Download PDF Visit The Full Archive

Related Articles

Clinical Trial Pathology Improvements Recommended By Group Remaining Actions After Merit Review

January 12, 1979

NCI Lists ARRA Funding By Organ Site

September 18, 2009

New ACS Awards Total $18.4 Million

February 23, 1979

DCT Board Approves New Imaging Study In Split Vote, Small Grant Program

October 27, 1989

In Brief: NIH Call For Review Group Nominations Brings 8,000 Names For 400 Vacancies

August 17, 1979

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

September 28, 2001